Crowley John F's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Jan 11, 2024
- Accession no.
- 0000950170-24-004042
- Filed
- Jan 11, 2024
- Trade date
- Jan 9-10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $431.5K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000950170-24-032406 (Mar 15, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crowley John FCIK 0001400973 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 | Common Stock | FTax withholdingDisposed | −36,865 | $13.65 | −$503,207.25 | 901,007 | Direct | |
| Jan 10, 2024 | Common Stock | SSaleDisposed | −31,614 | $13.65 | −$431,531.1 | 869,393 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.